Showing results (1801-1810 of 1,877) with videos related to

Sort By:
Pageof 188
The Korean Journal of Internal Medicine|December 14, 2017
No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndromeSang Kyun Sohn, Joon Ho Moon, In Hee Lee, et al.
Annals of Hematology|March 28, 2014
Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry studySukjoong Oh, Dong Hoe Koo, Min-Jung Kwon, et al.
International Journal of Cancer|June 25, 2022
Randomized multicenter phase II trial of prophylactic irradiation of para-aortic lymph nodes in advanced cervical cancer according to tumor hypoxia: Korean Radiation Oncology Group (KROG 07-01) studyMeesun Yoon, Hyo Kyung Lee, Eun Young Park, et al.
American Journal of Hematology|August 24, 2017
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapyHyungwoo Cho, Dok Hyun Yoon, Jung Bok Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2014
A nomogram predicting the risks of distant metastasis following postoperative radiotherapy for uterine cervical carcinoma: a Korean radiation oncology group study (KROG 12-08)Hyoung Uk Je, Seungbong Han, Young Seok Kim, et al.
Nature Communications|August 26, 2021
Excitatory synapses and gap junctions cooperate to improve Pv neuronal burst firing and cortical social cognition in Shank2-mutant miceEunee Lee, Seungjoon Lee, Jae Jin Shin, et al.
Oncotarget|November 8, 2017
The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)Sung-Hoon Jung, Je-Jung Lee, Kihyun Kim, et al.
Lancet (London, England)|May 30, 2026
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trialGeorg Lenz, Marek Trněný, John M Burke, et al.
Plos One|June 30, 2018
Correction: Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical featuresKee Hong Park, Patrick Waters, Mark Woodhall, et al.
Oral Oncology|October 12, 2025
A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinomaMin Hee Hong, Seoyoung Lee, Chang Gon Kim, et al.
Pageof 188